StockData
ALXONasdaqPharmaceutical PreparationsFiscal year ends December 31

ALX ONCOLOGY HOLDINGS INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.14+0.08 (+7.55%)

Close on Oct 19, 2026

Market cap
$154.63M
P/E (TTM)
–
Dividend yield
–

ALX ONCOLOGY HOLDINGS INC revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Alx Oncology does not break out revenue by segment, region or product in the tagged data of its filings for this period type.